HPV self-sampling for cervical cancer screening: a systematic review of values and preferences
Open accessAbstract
Introduction: The WHO recommends human papillomavirus (HPV) cervical self-sampling as an additional screening method and HPV DNA testing as an effective approach for the early detection of cervical cancer for women aged ≥30 years. This systematic review assesses end user’s values and preferences related to HPV self-sampling. Methods: We searched four electronic databases (PubMed, Cumulative Index to Nursing and Allied Health Literature, Latin American and Caribbean Health Sciences Literature and Embase) using search terms for HPV and self-sampling to identify articles meeting inclusion criteria. A standardised data extraction form was used to capture study setting, population, sample size and results related to values and preferences. Results: Of 1858 records retrieved, 72 studies among 52 114 participants published between 2002 and 2018 were included in this review. Almost all studies were cross-sectional surveys. Study populations included end users who were mainly adolescent girls and adult women. Ages ranged from 14 to 80 years. Most studies (57%) were conducted in high-income countries. Women generally found HPV self-sampling highly acceptable regardless of age, income or country of residence. Lack of self-confidence with collecting a reliable sample was the most commonly cited reason for preferring clinician-collected samples. Most women preferred home-based self-sampling to self-sampling at a clinic. The cervical swab was the most common and most accepted HPV DNA sampling device. Conclusions: HPV self-sampling is generally a highly accepted method of cervical cancer screening for end users globally. End user preferences for self-sampling device, method and setting can inform the development of new and expanded interventions to increase HPV screening.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review synthesizes 72 studies among 52,114 participants on end users’ values and preferences for HPV self-sampling for cervical cancer screening. It finds HPV self-sampling is generally highly acceptable globally, with most women preferring self-sampling over clinician sampling, though confidence in sample accuracy and access to a provider remain concerns.
Key findings
- Across 72 studies among 52,114 participants published between 2002 and 2018, with ages ranging from 14 to 80 years, HPV self-sampling was generally highly acceptable regardless of age, income or country of residence; 57% of participants were from high-income countries.
- Most end users preferred self-sampling over clinician sampling, citing less pain or physical discomfort, ease of use, convenience, privacy, and less embarrassment or anxiety; lack of self-confidence in collecting a reliable sample was the most commonly cited reason for preferring clinician-collected samples.
- Most women preferred home-based self-sampling to self-sampling at a clinic; the cervical swab was the most common and most accepted HPV DNA sampling device.
- Device preference varied: in rural Gambian women, acceptability was over 70% for all methods but preference was cervical swab 97.1%, tampon 84.4%, and clinician cervical brush 72.4%; among HIV-positive South African women, 51% preferred the cervical brush, 31% the tampon, and 18% the lavage sampler. For urine self-sampling, 95% of Micronesian women were comfortable with the urine test versus 82% for Pap smear, but more preferred clinician Pap smear (44.2%) over self-sampling (38.8%).
Methods
- Systematic review conducted according to PRISMA; searched PubMed, Cumulative Index to Nursing and Allied Health Literature, Latin American and Caribbean Health Sciences Literature, and Embase through 19 October 2018, plus hand-searching and secondary searching; included qualitative and quantitative studies of cervicovaginal or urine HPV self-sampling that measured acceptability or setting preference.
- Included 72 unique studies with 52,114 participants; two reviewers independently extracted data using a standardised form, resolved differences through consensus, and stratified findings by age, location, self-sampling device, setting, and subpopulation; quality was assessed with a matrix modified from the Evidence Project risk of bias tool and CASP checklist.
Limitations
- Stated: conference abstracts and grey literature were excluded, so findings may not fully represent the literature; diversity of measures used to assess values and preferences made comparisons across studies difficult.
- Stated in quality assessment: common issues were sampling/selection bias (27 articles), lack of validation of survey measures, and lack of transferability (32 articles); only 3 of 72 studies were conducted in low-income countries.
- Evident from the text: almost all studies were cross-sectional surveys, and 57% of participants were from high-income countries, limiting generalisability to low-resource settings and causal inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
26 of 39 cited sources checked · 16 supported · 2 flagged · accuracy not yet measured
- Premisecitation
Among AGYW attending a teen health centre in the USA, most participants expressed a preference for clinician sampling.
“However, most participants expressed a preference for clinician sampling.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [63] source
The Methods (Study Design; page unavailable) describe a nationwide online panel of lesbian and bisexual women aged 21–26, not attendees of a teen health centre. The Results (HPV Self-Testing; page unavailable) report that 44% would rather go to a doctor for screening, not most participants; 51% were willing to self-test at home. The paper did not directly measure a preference between clinician and self-sampling. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
HPV DNA self-sampling has been associated with improved participation in cervical cancer screening studies in low-income and middle-income countries.
“and has been associated with improved participation in cervical cancer screening studies in low-income and middle-income countries.14”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] source
The Abstract (page not specified) reports improved screening participation with self-collected HPV testing. But it says the ten studies reviewed were in Europe and North America, so its findings do not establish improved participation in studies in low- and middle-income countries. (LLM, conf=0.91)
Experimental — accuracy not yet measured
- Premisecitation
In a study of Swedish women with CIN, 85% of participants rated self-sampling procedures (urine and cervical swab) as easy.
“In a study of Swedish women with CIN, 85% of participants rated self-sampling procedures (urine and cervical swab) as easy”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [66] Andersson, 2018, Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?, PLoS One source
The Results section reports that over 85% of participants considered self-collection easy to carry out. The Methods section says participants self-collected urine and vaginal-fluid samples; cervical scrape samples were collected by clinicians, not by self-sampling. Thus the percentage is supported, but the claim's description of a self-collected cervical swab is not. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
In the same sample of Micronesian women, more women preferred a clinician to perform a Pap smear (44.2%) over self-sampling (38.8%).
“Despite higher ratings for urine self-sampling, more women preferred a clinician to perform a Pap smear (44.2%) over self-sampling (38.8%) because they valued the knowledge and expertise of the clinician.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [30] Sy, 2017, Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in YAP, Federated states of Micronesia, Cancer Epidemiol source
The women research participant survey (Results §3.1; page not provided) reports that 44.2% preferred a doctor or nurse to perform the Pap smear, compared with 38.3% who preferred providing their own urine sample—not 38.8%. The focus group findings (Results §3.3; page not provided) link the preference for clinician collection to participants’ confidence in skilled, knowledgeable screeners. (LLM, conf=0.93)
Experimental — accuracy not yet measured
- Premisecitation
In a sample of Micronesian women, 95% of participants said they were comfortable with the urine test compared with 82% for the Pap smear.
“In a sample of Micronesian women, 95% of participants said they were comfortable with the urine test compared with only 82% for the Pap smear.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [30] Sy, 2017, Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in YAP, Federated states of Micronesia, Cancer Epidemiol source
- Premisecitation
Among South African students aged 16-22 years, 56% preferred self-sampling over clinician sampling.
“Among South African students aged 16–22 years, 56% preferred self-sampling (56%) over clinician sampling.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [54] Mbatha, 2017, Self-Sampling for human papillomavirus testing among rural young women of KwaZulu-Natal, South Africa, BMC Res Notes source
- Premisecitation
In a sample of HIV-positive and HIV-negative women from northern Brazil, 87% found cervicovaginal sampling for HPV DNA acceptable.
“One study surveyed a sample of HIV-positive and HIV-negative women from northern Brazil, reporting that 87% of women found cervicovaginal sampling for HPV DNA acceptable.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [60] Rodrigues, 2018, Cervico-Vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors, Gynecol Oncol source
- Findingcitation
Other studies found that older women were more likely to prefer self-sampling over clinician sampling.
“Other studies found that older women were more likely to prefer self-sampling over clinician sampling.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [24] Fargnoli, 2015, To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland, Int J Womens Health source
The Results report a generational difference: some older women were more in favor of self-sampling than younger women, particularly after a bad experience with pelvic examinations. But the qualitative finding does not establish that older women generally preferred self-sampling over clinician sampling; the Conclusion says most participants preferred a gynecological visit. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [40] Wong, 2018, Can human papillomavirus DNA self-sampling be an acceptable and reliable option for cervical cancer screening in female sex workers?, Cancer Nurs source
- cites [42] Ilangovan, 2016, Acceptability and feasibility of human papilloma virus self-sampling for cervical cancer screening, J Womens Health source
- Premisecitation
In that study, women across all study sites preferred to conduct self-sampling in a clinic setting rather than at home so that a provider could clarify questions or do the test if needed.
“Women across all study sites preferred to conduct self-sampling in a clinic setting rather than at home so that a provider could clarify questions or do the test if needed.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [70] source
The Results section (‘Preference of self sampling at a clinic’; page unavailable) reports that some respondents preferred the clinic because a provider could collect the sample if needed, among other reasons. The Abstract reports that most women preferred clinic-based screening, but does not establish that preference separately for every site. The Discussion attributes the specific reason that a provider could clarify questions to women in a separate Mexican study, not to participants across this paper’s study sites. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
In an online survey of lesbian and bisexual AGYW in the USA, 51% reported willingness to self-sample at home.
“In an online survey of lesbian and bisexual AGYW in the USA, 51% participants reported willingness to self-sample at home.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [63] source
- Premisecitation
In that study of Swedish women with CIN, 74% said they could see themselves self-sampling at home.
“74% said they could see themselves self-sampling at home.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [66] Andersson, 2018, Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?, PLoS One source
- Premisecitation
Some transmale participants cited feelings of gender dysphoria and difficulty positioning the body or swab for self-sampling as challenges of self-sampling.
“Some participants cited feelings of gender dysphoria and difficulty positioning the body or swab for self-sampling as challenges of self-sampling.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [62] Reisner, 2018, Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients, PLoS One source
- Premisecitation
Among transmales who had undergone both self-sampling and clinician sampling for HPV DNA, 90% expressed a preference for self-sampling.
“Among transmales who had undergone both self-sampling and clinician sampling for HPV DNA, 90% expressed a preference for self-sampling citing privacy, ease and self-empowerment as reasons for their preference.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [62] Reisner, 2018, Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients, PLoS One source
- Premisecitation
In that Brazilian sample, a greater proportion of HIV-positive women reported acceptability (97%) than HIV-negative women (84%).
“A greater proportion of HIV-positive women reported acceptability (97%) than HIV-negative women (84%).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [60] Rodrigues, 2018, Cervico-Vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors, Gynecol Oncol source
The Results section (‘Acceptability of CVSC’) reports higher acceptance among HIV-infected women than HIV-uninfected women, but gives the figures as 95% (39/41) and 84% (94/112), respectively. The claimed 97% for HIV-positive women does not match the reported acceptability figure. (LLM, conf=0.92)
Experimental — accuracy not yet measured
- Findingown data
The review identified 72 unique studies presenting values and preferences data on HPV self-sampling.
“we identified 72 unique studies presenting values and preferences data on HPV self-sampling”
Quote in the paperSubstantial claim - Findingcitation
Even among end users that preferred self-sampling, many lacked confidence in the accuracy of self-sampled specimens.
“Even among end users that preferred self-sampling, many lacked confidence in accuracy of self-sampled specimens.24 25 27–29 33 35–37 39–41 47 49 52–55 57 59 62–66 69 70 73 78–80 85 94”
Quote in the paperNot a substantial claim - Findingcitation
In nine studies, end users preferred clinician sampling over self-sampling.
“In nine studies, end users preferred clinician sampling over self-sampling.25 28 30 53 57 64 73 76 87”
Quote in the paperNot a substantial claim - Findingcitation
Ability to perform the test in private was among the most frequently cited reasons for preferring self-sampling over clinician sampling.
“The most frequently cited reasons for preferring self-sampling over clinician sampling were less pain or physical discomfort,29 31 32 34–37 39 43 44 52 57 58 65 70 71 73 77–80 86 88–91 93–95 ease of use, convenience, ability to perform the test in private28 29 31–33 36 39 42 46 52 57 59 62 74 77 81 89 90 94 and less embarrassment or anxiety.”
Quote in the paperNot a substantial claim - Findingcitation
Less pain or physical discomfort was among the most frequently cited reasons for preferring self-sampling over clinician sampling.
“The most frequently cited reasons for preferring self-sampling over clinician sampling were less pain or physical discomfort,29 31 32 34–37 39 43 44 52 57 58 65 70 71 73 77–80 86 88–91 93–95 ease of use, convenience, ability to perform the test in private28 29 31–33 36 39 42 46 52 57 59 62 74 77 81 89 90 94 and less embarrassment or anxiety.”
Quote in the paperNot a substantial claim - Findingcitation
Self-sampling was generally highly acceptable regardless of age, income or country of residence.
“Self-sampling was generally highly acceptable regardless of age, income or country of residence.”
Quote in the paperSubstantial claim - Findingcitation
Ease of use and convenience were among the most frequently cited reasons for preferring self-sampling over clinician sampling.
“The most frequently cited reasons for preferring self-sampling over clinician sampling were less pain or physical discomfort,29 31 32 34–37 39 43 44 52 57 58 65 70 71 73 77–80 86 88–91 93–95 ease of use, convenience, ability to perform the test in private28 29 31–33 36 39 42 46 52 57 59 62 74 77 81 89 90 94 and less embarrassment or anxiety.”
Quote in the paperNot a substantial claim - Findingreasoning
Concerns about confidence in self-sampling were expressed in both high-income and low-income settings.
“These concerns were expressed in both high-income and low-income settings.”
Quote in the paperNot a substantial claim - Findingcitation
Less embarrassment or anxiety was among the most frequently cited reasons for preferring self-sampling over clinician sampling.
“The most frequently cited reasons for preferring self-sampling over clinician sampling were less pain or physical discomfort,29 31 32 34–37 39 43 44 52 57 58 65 70 71 73 77–80 86 88–91 93–95 ease of use, convenience, ability to perform the test in private28 29 31–33 36 39 42 46 52 57 59 62 74 77 81 89 90 94 and less embarrassment or anxiety.”
Quote in the paperNot a substantial claim - Findingcitation
Thirty-two articles reported that their results were not transferable to the study population or entire geographic population.
“Thirty-two articles reported that their results were not transferable to the study population or entire geographic population.25 26 29 35–40 46 53 57 59 62 64–67 70 72 75 77–81 87 88 91 93–95”
Quote in the paperNot a substantial claim - Findingcitation
One study acknowledged that participants self-selected to participate with the knowledge that self-collection would be a critical component of the study, so there may have been some selection bias towards acceptability of the self-test.
“one study acknowledged that participants self-selected to participate with the knowledge that self-collection would be a critical component of the study, so there may have been some selection bias towards acceptability of the self-test.43”
Quote in the paperNot a substantial claim - Findingcitation
Nine studies employed a qualitative design, specifically in-depth interviews and focus group discussions, to explore women's preferences related to HPV self-sampling.
“Nine studies employed a qualitative design, specifically in-depth interviews and focus group discussions, to explore women’s preferences related to HPV self-sampling.24–32”
Quote in the paperNot a substantial claim - Findingcitation
Fourteen studies specifically targeted women who were under-screened or never screened for cervical cancer.
“Fourteen studies specifically targeted women who were under/never screened for cervical cancer.24 26 30 31 37 38 41–48”
Quote in the paperNot a substantial claim - Findingown data
Twenty-seven articles reported sampling or selection bias as a limitation of the study.
“Twenty-seven articles reported sampling or selection bias as a limitation of the study.26 27 29 35–37 39 40 43 46 52 54 57 59 61–64 66 70 83 87 89 91 93 95 96”
Quote in the paperNot a substantial claim - Findingcitation
Across most of the studies asking end users' preference regarding self-sampling versus clinician sampling for HPV DNA, most end users chose self-sampling.
“Across most of the studies asking end users’ preference regarding self-sampling versus clinician sampling for HPV DNA, most end users chose self-sampling.29 35 36 42 43 52 54 56 58 59 62 65 68 69 71 74 77–86 88 89 91–93 95”
Quote in the paperSubstantial claim - Findingreasoning
End users expressed greater confidence in the clinician's ability to collect the specimen properly.
“End users expressed greater confidence in the clinician’s ability to collect the specimen properly.”
Quote in the paperNot a substantial claim - Findingcitation
In clinical settings, end users cited the important role of a trusted healthcare provider in fielding questions and providing reassurance that sampling was done correctly.
“In clinical settings, end users cited the important role of a trusted healthcare provider in fielding questions and providing reassurance that sampling was done correctly.27 30 47 70”
Quote in the paperNot a substantial claim - Findingcitation
In 21 studies, end users self-sampled from their homes.
“In 21 studies, end users self-sampled from their homes.26 33 35–38 43 45 46 49 58 59 69 72 74 81 82 84 85 92 93”
Quote in the paperNot a substantial claim - Findingcitation
In a sample of rural Gambian women, all three methods (self-sampling using cervical swab, self-sampling using tampon, and clinician sampling using cervical brush) were found acceptable by more than 70% of participants.
“Though all three methods were found to acceptable by more than 70% of participants”
Quote in the paperNot a substantial claim - Findingcitation
In rural Gambian women, there was a clear preference for self-sampling using the cervical swab (97.1%) over self-sampling using tampon (84.4%) and clinician sampling using cervical brush (72.4%).
“there was a clear preference for self-sampling using the cervical swab (97.1%) over self-sampling using tampon (84.4%) and clinician sampling using cervical brush (72.4%).”
Quote in the paperNot a substantial claim - Findingcitation
When asked to compare self-sampling at home versus in a clinic, most end users expressed a preference to collect the sample at home.
“When asked to compare self-sampling at home versus in a clinic, most end users expressed a preference to collect the sample at home.32 33 44 58 66 68 74 91”
Quote in the paperSubstantial claim - Findingcitation
In two studies, end users reported a clear preference for clinic-based testing with a physician over self-sampling at home.
“In two studies, end users reported a clear preference for clinic-based testing with a physician over self-sampling at home.57 70”
Quote in the paperNot a substantial claim - Findingown data
Lack of self-confidence with collecting a reliable sample was the most commonly cited reason for preferring clinician-collected samples.
“Lack of self-confidence with collecting a reliable sample was the most commonly cited reason for preferring clinician-collected samples.”
Quote in the paperNot a substantial claim - Findingcitation
Other studies suggested strategies to increase end users' confidence in performing self-sampling correctly.
“Other studies suggested strategies to increase end user’s confidence in performing self-sampling correctly.47 55 70”
Quote in the paperNot a substantial claim - Findingown data
Of the 25 studies comparing age groups, 14 found no differences in preferences for self-sampling versus clinician sampling between older and younger women.
“Of these, 14 studies found no differences in preferences for self-sampling versus clinician sampling comparing older versus younger women.”
Quote in the paperNot a substantial claim - Findingcitation
Five studies reported greater preference for self-sampling among younger age groups compared with older age groups.
“Five studies reported greater preference for self-sampling among younger age groups compared with older age groups.”
Quote in the paperNot a substantial claim - Findingcitation
Only one study compared end users' preferences across different regions and countries.
“Only one study compared end users’ preferences across different regions and countries.”
Quote in the paperNot a substantial claim - Findingnone given
Studies presenting preferences or attitudes adjusted for sociodemographic and/or behavioural characteristics were more likely to find no difference in preference for self-sampling by age group.
“Studies presenting preferences or attitudes adjusted for sociodemographic and/or behavioural characteristics were more likely to find no difference in preference for self-sampling by age group.”
Quote in the paperNot a substantial claim - Findingcitation
Twenty-five studies compared differences in sampling preferences by age group.
“Twenty-five studies compared differences in sampling preferences by age group.”
Quote in the paperNot a substantial claim - Findingreasoning
Across studies, the home was regarded as a highly acceptable and convenient setting for self-sampling.
“Across studies, the home was regarded as a highly acceptable and convenient setting for self-sampling.”
Quote in the paperSubstantial claim - Findingcitation
Women who preferred clinician sampling expressed concerns about the reliability of self-sampled specimens.
“Women who preferred clinician sampling expressed concerns about the reliability of self-sampled specimens”
Quote in the paperNot a substantial claim - Findingown data
Only 15 studies examined alternative self-sampling devices and methods.
“however, only 15 studies examined these alternative self-sampling devices and methods.”
Quote in the paperSubstantial claim - Findingown data
Studies examining less commonly used devices and methods generally found high acceptability.
“Studies examining less commonly used devices (eg, tampon and labial padette) and methods (eg, urine sampling) generally found high acceptability”
Quote in the paperNot a substantial claim - Findingown data
Women generally preferred self-sampling over clinician sampling, citing ease of use, privacy, convenience and physical and emotional comfort as major reasons for their preference.
“Women generally preferred self-sampling over clinician sampling, citing ease of use, privacy, convenience and physical and emotional comfort as major reasons for their preference.”
Quote in the paperSubstantial claim - Findingnone given
Women expressed that they would prefer clinic-based sampling if home-based sampling meant they would not have access to a healthcare provider.
“However, women expressed that they would prefer clinic-based sampling if home-based sampling meant they would not have access to a healthcare provider.”
Quote in the paperSubstantial claim - Findingnone given
Among studies comparing acceptability of different self-sampling devices, end users preferred the cervical swab over other devices such as the lavage or cervical brush.
“Among studies comparing acceptability of different self-sampling devices, end users preferred the cervical swab over other devices such as the lavage or cervical brush”
Quote in the paperNot a substantial claim - Findingown data
End user concern that they would not get face time with a clinician if needed is a common reason for disliking self-sampling identified uniquely in this review.
“Another common reason identified uniquely in this review is end user concern that they would not get face time with a clinician if needed.”
Quote in the paperNot a substantial claim - Findingnone given
High levels of acceptability were consistent among vulnerable and underscreened subpopulations.
“Similarly, high levels of acceptability were consistent among vulnerable and underscreened subpopulations.”
Quote in the paperSubstantial claim - Findingnone given
The most common device for self-sampling was the cervical swab.
“The most common device for self-sampling was the cervical swab.”
Quote in the paperNot a substantial claim - Findingreasoning
More than half of home-based self-sampling studies took place in high-income countries.
“More than half of home-based self-sampling studies took place in high-income countries, since a quick and reliable postal system was necessary for mailing the samples for processing.”
Quote in the paperNot a substantial claim - Findingown data
In this systematic review, we found general consensus that self-sampling is a highly acceptable method for HPV testing, regardless of study location and sampling method, device, setting or participant demographics.
“In this systematic review, we found general consensus that self-sampling is a highly acceptable method for HPV testing, regardless of study location and sampling method, device, setting or participant demographics.”
Quote in the paperSubstantial claim - Premisecitation
End users' values and preferences regarding self-sampling method, device and setting have not been explored.
“Although previous reviews have found generally high acceptability of HPV DNA self-sampling, end users’ values and preferences regarding self-sampling method, device and setting have not been explored.13 15–17”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 13 15–17
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Cervicovaginal HPV DNA specimens can also be reliably collected by end users themselves, a process known as self-sampling.
“However, cervicovaginal HPV DNA specimens can also be reliably collected by end users themselves—a process known as self-sampling.10–12”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
HPV DNA self-sampling is generally a highly acceptable method for the purposes of cervical cancer screening.
“Generally, HPV DNA self-sampling is a highly acceptable method for the purposes of cervical cancer screening13”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] source
- Interpretationreasoning
HPV self-sampling is generally a highly accepted method of cervical cancer screening for end users globally.
“HPV self-sampling is generally a highly accepted method of cervical cancer screening for end users globally.”
Quote in the paperSubstantial claim - Premisecitation
In one study, Dutch young women cited decreased embarrassment, time/effort investment and a 'do-it-yourself' attitude more often than older women when describing why they preferred HPV self-sampling over clinician sampling.
“In one study, Dutch young women cited reasons of decreased embarrassment, time/effort investment and a ‘do-it-yourself’ attitude more often than older women when describing why they preferred HPV self-sampling over clinician sampling.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Bosgraaf, 2014, Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women, Prev Med source
- May combine two claims. 32
- Classified as probably not a substantial claim. 28
May combine two claims.
PremisecitationAmong AGYW attending a teen health centre in the USA, acceptability for both self-sampling and clinician sampling was high.
“Among AGYW attending a teen health centre in the USA, acceptability for both self-sampling and clinician sampling was high.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [63] source
Methods (Study Design; page unavailable) says participants were lesbian and bisexual women aged 21–26 recruited through an online LGBT panel, not attendees of a teen health centre. Results (HPV Self-Testing; page unavailable) reports 51% willing to use an HPV self-test at home, rather than high acceptability for both self- and clinician sampling; clinician-sampling acceptability was not measured. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHPV DNA testing is recommended by WHO, the US Preventive Services Task Force and Australian, US and European national screening programme guidelines as an effective approach for the early detection of cervical cancer for women aged 30 years and older.
“HPV DNA testing is recommended by WHO, the US Preventive Services Task Force and Australian, US and European national screening programme guidelines as an effective approach for the early detection of cervical cancer for women ≥30 years.7–9”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [7] World Health Organization . Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention, 2013. Available: https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [8] source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [9] Moyer, 2012, Screening for cervical cancer: U.S. preventive services Task force recommendation statement, Ann Intern Med source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
“We conducted this systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.21”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [21] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationA coding matrix was modified from the Evidence Project risk of bias tool and the Critical Appraisal Skills Program checklist for qualitative studies to facilitate data extraction related to quality assessment.
“A coding matrix was modified from the Evidence Project risk of bias tool23 and the Critical Appraisal Skills Program checklist for qualitative studies to facilitate data extraction related to quality assessment.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [23] source
May combine two claims.
PremisecitationA qualitative study of women in Switzerland found that younger women were used to visiting a gynaecologist and did not see the necessity of changing this practice.
“A qualitative study of women in Switzerland found that younger women were used to visiting a gynaecologist and did not see the necessity of changing this practice”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Fargnoli, 2015, To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland, Int J Womens Health source
May combine two claims.
PremisecitationIn that study, women in rural Uttar Pradesh (93.1%), Hyderabad (95.5%), Uganda (64.5%) and Nicaragua (50.0%) preferred self-sampling over clinician sampling.
“The study found that women in rural Uttar Pradesh (93.1%), Hyderabad (95.5%), Uganda (64.5%) and Nicaragua (50.0%) preferred self-sampling over clinician sampling.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [70] source
Table 2 in Results > Ease and preference of self-sampling reports the four self-sampling percentages exactly as quoted. But in Nicaragua, 50.0% preferred self-collection and 50.0% preferred provider collection, so women there did not prefer self-sampling over clinician sampling. (LLM, conf=0.91)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn that Swiss study, some older women, less used to regular gynaecological appointments, were more in favour of self-sampling, especially if they previously had had a negative experience with pelvic examinations.
“while some older women, less used to regular gynaecological appointments, were more in favour of self-sampling, especially if they previously had had a negative experience with pelvic examinations.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Fargnoli, 2015, To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland, Int J Womens Health source
May combine two claims.
PremisecitationIn that study, more than half of surveyed respondents in each site reported self-sampling as 'easy', with the lowest percentage in Hyderabad (53.6%) and the highest in Uganda (89.7%).
“More than half of surveyed respondents in each site reported self-sampling as ‘easy’ with the lowest percentage in Hyderabad (53.6%) and the highest percentage in Uganda (89.7%).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [70] source
May combine two claims.
PremisecitationWillingness to self-sample at home among lesbian and bisexual AGYW increased with age and concern about getting an HPV-related disease.
“Willingness increased with age and concern about getting an HPV-related disease.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [63] source
May combine two claims.
PremisecitationAmong HIV-positive women in South Africa, rural women preferred the cervical brush over other sampling devices, whereas urban women preferred the tampon over other devices.
“HIV-positive rural women preferred the cervical brush over other sampling devices, whereas urban women preferred the tampon over other devices.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [51] Mahomed, 2014, Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa, Pan Afr Med J source
May combine two claims.
InterpretationcitationHPV DNA self-sampling is a promising screening method that, when offered to women in low-resource settings, can address barriers that create inequalities in access to cervical cancer screening.
“HPV DNA self-sampling is a promising screening method that, when offered to women in low-resource settings, can address barriers that create inequalities in access to cervical cancer screening.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [97] Defo VF , JFJAjoe D . Why consider self-sampling for cervical cancer screening in Low-and middle-income countries? 2020;22:116–25. source
May combine two claims.
InterpretationcitationScreening with high uptake will expedite reductions and will be necessary to eliminate cervical cancer in countries with the highest burden.
“Screening with high uptake will expedite reductions and will be necessary to eliminate cervical cancer in countries with the highest burden.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [98] Brisson, 2020, Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries, The Lancet source
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe 72 included studies included a total of 52,114 participants.
“The 72 studies included a total of 52 114 participants”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the included participants, 57% were from high-income countries.
“Of the included participants, 57% were from high-income countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataStudies were conducted in a variety of countries, including all WHO regions and all World Bank country income classification categories.
“Studies were conducted in a variety of countries, including all WHO regions and all World Bank country income classification categories (high, middle and low income).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenParticipants ranged in age from 14 to 80 years.
“Participants ranged in age from 14 to 80 years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCommon issues with study quality were sampling/selection bias, lack of validation of survey measures and lack of transferability of values and preferences results.
“Common issues with study quality were sampling/selection bias, lack of validation of survey measures and lack of transferability of values and preferences results.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOther study quality concerns identified included no consideration of study limitations, preference bias due to patient-physician interaction, recall bias, social desirability bias, low response rate and high loss to follow-up.
“Other study quality concerns identified in this review included: no consideration of study limitations, preference bias due to patient–physician interaction, recall bias, social desirability bias, low response rate and high loss to follow-up.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataStudy populations typically included adult end users.
“Study populations typically included adult end users.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationFive studies employed a multimethod or mixed methods design.
“Five studies employed a multimethod or mixed methods design.47 67–70”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSix qualitative studies asked about hypothetical acceptability of HPV self-sampling.
“Six qualitative studies asked about hypothetical acceptability of HPV self-sampling.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataArticles were published between 2002 and 2018, with 50% published since 2015.
“Articles were published between 2002 and 2018, with 50% published since 2015.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSample sizes for individual included studies ranged from 17 to 9484.
“sample sizes for individual studies ranged from 17 to 9484”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOne study assessed test-retest reliability and content validity of acceptability measures, but psychometric properties of acceptability were not conducted consistently across studies.
“One study assessed test–retest reliability and content validity of acceptability measures,64 but psychometric properties of acceptability were not conducted consistently across studies.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationEnd users generally found HPV self-sampling acceptable and/or expressed willingness to undergo future HPV testing using self-sampling.
“End users generally found HPV self-sampling acceptable and/or expressed willingness to undergo future HPV testing using self-sampling.24 26 27 30 32 34 36–39 41 42 44 46 47 50 53 54 56 58 60–63 66–69 71 73 74 79–85 87–93 95”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA total of 58 studies employed a quantitative approach: 47 cross-sectional studies, two pre-post surveys, eight RCTs and one prospective cohort.
“A total of 58 studies employed a quantitative approach: 47 cross-sectional studies,41–46 48 50–63 65 66 71–94 two pre–post surveys,64 95 eight RCTs33–40 and one prospective cohort.49”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAlmost all included studies were cross-sectional surveys, though some study designs included in-depth interviews and/or focus group discussions.
“Almost all studies were cross-sectional surveys, though some study designs included in-depth interviews and/or focus group discussions.24–32”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMost (n=67) quantitative studies focused on end users in high-income countries, while only 15 quantitative studies were conducted in low-income or lower middle-income countries.
“Most (n=67) quantitative studies focused on end users in high-income countries, while only 15 quantitative studies were conducted in low-income or lower middle-income countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationTwo qualitative studies examined cervicovaginal self-sampling device preferences, two examined urine self-sampling and one examined self-sampling with a labial padette.
“Two qualitative studies examined cervicovaginal self-sampling device preferences,26 28 two examined urine self-sampling30 66 and one examined self-sampling with a labial padette.29”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the nine qualitative studies, seven were conducted in high-income countries in Europe and North America.
“Of the nine qualitative studies, seven were conducted in high-income countries in Europe and North America24–29 31”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationReasons for preferring clinic-based testing were lack of confidence in ability to self-sample and ability to receive treatment if needed.
“Reasons for preferring clinic-based testing were lack of confidence in ability to self-sample57 and ability to receive treatment if needed.70”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenPreferences related to self-sampling including sampling device, method and setting varied by region, subpopulation and age, though most end users found the process of self-sampling acceptable overall.
“Preferences related to self-sampling including sampling device (eg, swab, brush and tampon), method (eg, cervicovaginal and urine), setting (eg, home, clinic and community-based site) varied by region, subpopulation and age, though most end users found the process of self-sampling acceptable overall.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationClear, step-by-step instructions with illustrations in the appropriate language were suggested as methods to facilitate self-sampling and improve end users' confidence.
“In addition, clear, step-by-step instructions with illustrations in the appropriate language were suggested as methods to facilitate self-sampling and improve end users’ confidence.62 68 79 81”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenSelf-sampled specimens are seen as acceptable in terms of ease of use, convenience, privacy, and physical and emotional comfort, including decreased embarrassment, anxiety, and pain.
“Self-sampled specimens are seen as acceptable in terms of ease of use, convenience, privacy, and physical and emotional comfort (including decreased embarrassment, anxiety, and pain).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenIn high-income countries, samples collected at home were usually sent for processing using the postal service, whereas in some low-income and middle-income countries, self-sampled specimens were collected by community health workers conducting home visits for processing from the homes of participants rather than mail.
“In high-income countries, samples collected at home were usually sent for processing using the postal service, whereas in some low-income and middle-income countries, self-sampled specimens were collected by community health workers conducting home visits for processing from the homes of participants rather than mail.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe cervical swab was by far the most common and well accepted HPV DNA sampling device.
“The cervical swab was by far the most common and well accepted.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationMost women experiencing homelessness found the labial padette to be an acceptable form of self-sampling and preferred it over clinician sampling using a cervical brush, though some were concerned about reliability of the self-sampled specimens.
“Most women found the labial padette to be an acceptable form of self-sampling and was preferred over clinician sampling using a cervical brush though some women were concerned about reliability of the self-sampled specimens.29”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationSeveral studies assessed women's preferences for different self-sampling devices and acceptability was generally high for all devices.
“Several studies assessed women’s preferences for different self-sampling devices and acceptability was generally high for all devices.26 28 32–34 49–51 54 67 80 89”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn a sample of HIV-positive South African women, the highest preference was for the cervical brush (51%), while fewer women preferred the tampon (31%) or lavage sampler (18%).
“a sample of HIV-positive South African women rated the highest preference for the cervical brush (51%), while fewer women preferred the tampon (31%) or lavage sampler (18%).51”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOther devices tested included the lavage, cervical brush, tampon and labial padette.
“Other devices tested included the lavage,74 81 85 cervical brush,42–44 48 52 53 55 60 69 70 72 79 82 84 86–88 92 94 95 tampon32 34 49–51 and labial padette.29”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOnly 3 of the 72 studies included in this review were conducted in low-income countries, leaving a critical gap in understanding of end users' preferences in these settings.
“Only 3 of the 72 studies included in this review were conducted in low-income countries, leaving a critical gap in understanding of end users’ preferences in these settings.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenIn some low-income and middle-income countries, community health workers collected specimens self-sampled by participants for processing during home-visits.
“In some low-income and middle-income countries, community health workers collected specimens self-sampled by participants for processing during home-visits.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenHPV self-sampling is generally a highly accepted method of cervical cancer screening for women across the world.
“HPV self-sampling is generally a highly accepted method of cervical cancer screening for women across the world.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationTypically, per current recommendations, cervicovaginal samples for HPV DNA testing are collected by a clinician during a pelvic examination.
“Typically, per current recommendations, cervicovaginal samples for HPV DNA testing are collected by a clinician during a pelvic examination.8 9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 8 9
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn areas with high endemic HIV, WHO recommends that sexually active girls and women, regardless of age, should be screened as soon as they have tested positive for HIV.
“In addition, in areas with high endemic HIV, WHO recommends that sexually active girls and women, regardless of age, should be screened as soon as they have tested positive for HIV.7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] World Health Organization . Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention, 2013. Available: https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious reviews have found generally high acceptability of HPV DNA self-sampling.
“Although previous reviews have found generally high acceptability of HPV DNA self-sampling, end users’ values and preferences regarding self-sampling method, device and setting have not been explored.13 15–17”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 13 15–17
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenTwo reviewers independently assessed all full-text articles for study inclusion eligibility and resolved differences through consensus.
“Two reviewers independently assessed all full-text articles for study inclusion eligibility and resolved differences through consensus.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningEnd user preferences for self-sampling device, method and setting can inform the development of new and expanded interventions to increase HPV screening.
“End user preferences for self-sampling device, method and setting can inform the development of new and expanded interventions to increase HPV screening.”
Quote in the paperSubstantial claim- Rests on an assumption: HPV testing must be acceptable to end users, in particular those who are underscreened and most vulnerable to cervical cancer, for screening programmes to succeed.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningUnderstanding end users' preferences for self-sampling is critical for reaching the WHO global target of 70% HPV screening coverage by 2030.
“Understanding end users’ preferences for self-sampling is critical for reaching the WHO global target of 70% HPV screening coverage by 2030.”
Quote in the paperNot a substantial claim- Rests on an assumption: HPV testing must be acceptable to end users, in particular those who are underscreened and most vulnerable to cervical cancer, for screening programmes to succeed.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenTwo reviewers independently used a standardised data abstraction form to capture information on location of study, study population, sample size and results related to values and preferences from each study, and differences in data abstraction were resolved through consensus, with a third reviewer as needed.
“Two reviewers independently used a standardised data abstraction form to capture information on location of study, study population, sample size and results related to values and preferences from each study. Differences in data abstraction were resolved through consensus, with a third reviewer as needed.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe preference for cervical swab could be due to greater familiarity with cervical swab.
“but this preference could be due to greater familiarity with cervical swab.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningWe did not include conference abstracts or grey literature in this review, so our findings may not fully represent the full body of literature on values and preferences for HPV self-sampling.
“We did not include conference abstracts or grey literature in this review, so our findings may not fully represent of the full body of literature on values and preferences for HPV self-sampling.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningGiven the diversity of measures used to assess values and preferences, it is difficult to make comparisons across studies and therefore difficult to determine the specific aspects of self-sampling that clients find acceptable and whether these hold true for clients in different age groups, geographic regions and socioeconomic status.
“Given the diversity of measures used to assess values and preferences, it is difficult to make comparisons across studies and therefore difficult to determine the specific aspects of self-sampling that clients find acceptable and whether these hold true for clients in different age groups, geographic regions and socioeconomic status.”
Quote in the paperSubstantial claim
The paper relies on this without support.
WHO recommends HPV cervical self-sampling as an additional screening method.
“The WHO recommends human papillomavirus (HPV) cervical self-sampling as an additional screening method”
The paper relies on this without support.
HPV testing must be acceptable to end users, in particular those who are underscreened and most vulnerable to cervical cancer, for screening programmes to succeed.
“Understanding end users’ values and preferences related to self-sampling is critical because HPV testing must be acceptable to end users, in particular those who are underscreened and most vulnerable to cervical cancer.”
The paper relies on this without support.
Understanding women’s preferences for HPV self-sampling is a critical factor for expanding choice, coverage and uptake of cervical cancer screening.
“Understanding women’s preferences for HPV self-sampling is a critical factor for expanding choice, coverage and uptake of cervical cancer screening.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Reported minimum study size excludes a 15-person study
MinorThe stated minimum sample size is 17, but Table 2 lists Katz's study with a sample size of 15.
“sample sizes for individual studies ranged from 17 to 9484”
“| Katz,26 2017 | Brush; lavage; swab | Hypothetical | Home | USA: Appalachian Ohio | Rural women aged 30–65 years who had not received a Pap test in the past 3 years. | 15 | Qualitative |”
Eligibility requires performed self-sampling, but hypothetical-use studies are included
MinorThe inclusion criteria require participants who performed self-sampling, yet Table 2 includes studies classified as hypothetical rather than actual use.
“Studies were eligible for inclusion if they met the following criteria: (1) included participants who performed cervicovaginal or urine self-sampling for HPV DNA”
“| Reiter,63 2015 | Unspecified | Hypothetical | n/a | USA | Lesbian and bisexual women aged 21–26 years. | 418 | Quantitative |”
High-income quantitative study count exceeds all quantitative studies
MinorThe paper says 67 quantitative studies focused on high-income countries, but reports only 58 quantitative studies in total.
“Most (n=67) quantitative studies focused on end users in high-income countries”
“A total of 58 studies employed a quantitative approach”
A cited home self-sampling study is listed as clinic-based
MinorStudy 49 is cited among studies in which users self-sampled at home, but Table 2 gives its setting as clinic.
“In 21 studies, end users self-sampled from their homes.26 33 35–38 43 45 46 49 58 59 69 72 74 81 82 84 85 92 93”
“| Harper,49 2002b | Swab; tampon | Actual | Clinic | USA: New Hampshire | Women aged 18–68 years who attended an affiliated Dartmouth-Hitchcock teaching clinic with abnormal Pap smear findings or abnormal cervical cancer findings. | 103 | Quantitative |”
A quantitative urine study is called qualitative
MinorThe text includes study 66 among two qualitative studies examining urine self-sampling, while Table 2 classifies study 66 as quantitative.
“two examined urine self-sampling30 66”
“| Andersson,66 2018 | Swab; urine | Actual | Clinic | Sweden: Stockholm | Women who had undergone treatment of high-grade CIN2+. | 479 | Quantitative |”
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1× · see citing works
“21”
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,708 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,759 · see citing works
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,769 · see citing works
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30482-6 · Cited by 4,241 · see citing works
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196 · see citing works
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049 · see citing works
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943 · see citing works
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674 · see citing works
Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T. N., Bénard, É., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30157-4 · Cited by 650 · see citing works
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
Yeh, P. T., Kennedy, C. E., Vuyst, H. D., & Narasimhan, M. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001351 · Cited by 328 · cited 1× · see citing works
“The full search strategy is described in a complementary review of the effectiveness of HPV self-sampling compared with clinician sampling 22 ; the same search strategy was used for both the effectiveness review and this values and preferences review.”
MethodSelf-citationPetignat, P., Faltin, D. L., Bruchim, I., Tramèr, M. R., Franco, E. L., & Coutlée, F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.023 · Cited by 290 · see citing works
Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27790 · Cited by 265 · see citing works
von Karsa, L., Arbyn, M., De Vuyst, H., Dillner, J., Dillner, L., Franceschi, S., Patnick, J., Ronco, G., Segnan, N., Suonio, E., et al. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.06.006 · Cited by 253 · see citing works
The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis
Nelson, E. J., Maynard, B. R., Loux, T., Fatla, J., Gordon, R., & Arnold, L. D. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052609 · Cited by 252 · see citing works
Status of HPV vaccine introduction and barriers to country uptake
Gallagher, K. E., LaMontagne, D. S., & Watson‐Jones, D. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.003 · Cited by 247 · see citing works
Racey, C. S., Withrow, D. R., & Gesink, D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405681 · Cited by 232 · see citing works
Kennedy, C. E., Fonner, V. A., Armstrong, K. A., Denison, J. A., Yeh, P. T., O’Reilly, K. R., & Sweat, M. D. (2019) · Systematic Reviews · doi:10.1186/s13643-018-0925-0 · Cited by 212 · see citing works
Self-citationDzuba, I. G., Díaz, E. Y., Allen, B., Leonard, Y. F., Lazcano Ponce, E. C., Shah, K. V., Bishai, D., Lorincz, A., Ferris, D., Turnbull, B., et al. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902753668466 · Cited by 208 · see citing works
Bansil, P., Wittet, S., Lim, J. L., Winkler, J. L., Paul, P., & Jeronimo, J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-596 · Cited by 184 · see citing works
Gupta, S., Palmer, C., Bik, E. M., Cárdenas, J. P., Núñez, H., Kraal, L., Bird, S. W., Bowers, J., Smith, A. J., Walton, N. A., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00077 · Cited by 157 · see citing works
Reisner, S. L., Deutsch, M. B., Peitzmeier, S. M., White Hughto, J. M., Cavanaugh, T. P., Pardee, D. J., McLean, S. A., Panther, L. A., Gelman, M., Mimiaga, M. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190172 · Cited by 126 · see citing works
Madzima, T. R., Vahabi, M., & Lofters, A. (2017) · PubMed Central · Cited by 123 · see citing works
Acceptability of unsupervised HPV self-sampling using written instructions
Waller, J., McCaffery, K. J., Forrest, S., Szarewski, A., Cadman, L., Austin, J., & Wardle, J. (2006) · Journal of Medical Screening · doi:10.1177/096914130601300409 · Cited by 122 · see citing works
Nobbenhuis, M., Helmerhorst, T. J. M., van den Brule, A. J. C., Rozendaal, L., Jaspars, L. H., Voorhorst, F. J., Verheijen, R. H. M., & Meijer, C. J. L. M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.435 · Cited by 121 · see citing works
Harper, D. M., Noll, W. W., Belloni, D. R., & Cole, B. F. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121076 · Cited by 109 · see citing works
Szarewski, A., Cadman, L., Ashdown-Barr, L., et al. (2009) · Journal of Medical Screening · doi:10.1258/jms.2009.009069 · Cited by 105 · see citing works
Acceptability of Self-Collection of Specimens for HPV DNA Testing in an Urban Population
Anhang, R., Nelson, J. A., Telerant, R., Chiasson, M. A., & Wright, T. C. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.721 · Cited by 97 · see citing works
What is evidence-based medicine?
Montori, V. M., & Guyatt, G. H. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00015-4 · Cited by 94 · see citing works
Ketelaars, P. J. W., Bosgraaf, R. P., Siebers, A. G., Massuger, L. F. A. G., van der Linden, J. C., Wauters, C. A. P., Rahamat-Langendoen, J. C., van den Brule, A. J. C., IntHout, J., Melchers, W. J. G., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.05.021 · Cited by 93 · see citing works
Bosgraaf, R. P., Ketelaars, P. J. W., Verhoef, V. M. J., Massuger, L. F. A. G., Meijer, C. J. L. M., Melchers, W. J. G., & Bekkers, R. L. M. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.04.011 · Cited by 92 · see citing works
Modibbo, F. I., Iregbu, K. C., Okuma, J. O., Leeman, A., Kasius, A., de Koning, M. N. C., Quint, W. G. V., & Adebamowo, C. (2017) · Infectious Agents and Cancer · doi:10.1186/s13027-017-0123-z · Cited by 79 · see citing works
Gottschlich, A., Rivera-Andrade, A., Grajeda, E., Alvarez, C., Mendoza Montano, C., & Meza, R. (2017) · Journal of Global Oncology · doi:10.1200/jgo.2016.005629 · Cited by 72 · see citing works
Obiri‐Yeboah, D., Adu‐Sarkodie, Y., Djigma, F. W., et al. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0448-1 · Cited by 72 · see citing works
Howard, M., Lytwyn, A., Lohfeld, L. H., Redwood-Campbell, L. J., Fowler, N., & Karwalajtys, T. L. (2009) · Canadian Journal of Public Health · doi:10.1007/bf03405272 · Cited by 67 · see citing works
Human Papillomavirus Self-Sampling in Cameroon
Berner, A., Hassel, S. B., Tebeu, P. M., et al. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31826b7b51 · Cited by 67 · see citing works
Rosenbaum, A. J., Gage, J. C., Alfaro, K. M., Ditzian, L. R., Maza, M., Scarinci, I. C., Felix, J. C., Castle, P. E., Villalta, S., Miranda, E., et al. (2014) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2014.02.026 · Cited by 65 · see citing works
Racey, C. S., Gesink, D., Burchell, A. N., Trivers, S., Wong, T., & Rebbapragada, A. (2015) · Journal of Women s Health · doi:10.1089/jwh.2015.5348 · Cited by 63 · see citing works
Mao, C., Kulasingam, S., Whitham, H. K., Hawes, S. E., Lin, J. W., & Kiviat, N. B. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.5965 · Cited by 63 · see citing works
Education efforts may contribute to wider acceptance of human papillomavirus self-sampling
Crofts, V. L., Flahault, E., Tebeu, P. M., et al. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s56307 · Cited by 61 · see citing works
Ma'som, M., Bhoo‐Pathy, N., Nasir, N. H., Bellinson, J., Subramaniam, S., Ma, Y., Yap, S. H., Goh, P., Gravitt, P. E., & Woo, Y. L. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-011022 · Cited by 61 · see citing works
Reiter, P. L., & McRee, A.-L. (2015) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2014-101004 · Cited by 59 · see citing works
Zehbe, I., Moeller, H., Severini, A., Weaver, B., Escott, N. G., Bell, C., Crawford, S., Bannon, D., & Paavola, N. (2011) · BMJ Open · doi:10.1136/bmjopen-2010-000030 · Cited by 59 · see citing works
Igidbashian, S., Boveri, S., Spolti, N., et al. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2189 · Cited by 58 · see citing works
Patient Acceptance of Self-Sampling for Human Papillomavirus in Rural China
Tisci, S., Shen, Y., Fife, D., Huang, J., Goycoolea, J. M., Ma, C. P., Belinson, J. L., Huang, R.-D., & Qiao, Y. (2003) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200304000-00007 · Cited by 58 · see citing works
Acceptability of human papillomavirus self testing in female adolescents
Kahn, J. A. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.012047 · Cited by 57 · see citing works
Acceptability and feasibility of human papilloma virus self-sampling for cervical cancer screening
Ilangovan, K., Kobetz, E., Koru-Sengul, T., Marcus, E. N., Rodriguez, B., Alonzo, Y., & Carrasquillo, O. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5469 · Cited by 56 · see citing works
Zehbe, I., Wakewich, P., King, A.-D., Morrisseau, K., & Tuck, C. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017384 · Cited by 56 · see citing works
McLachlan, E., Anderson, S. L., Hawkes, D. J., Saville, M., & Arabena, K. (2018) · Current Oncology · doi:10.3747/co.25.3916 · Cited by 54 · see citing works
Mitchell, S. M., Pedersen, H., Stime, E. E., et al. (2017) · BMC Women s Health · doi:10.1186/s12905-016-0360-0 · Cited by 52 · see citing works
Arrossi, S., Ramos, S., Straw, C., Thouyaret, L., & Orellana, L. (2016) · BMC Public Health · doi:10.1186/s12889-016-3474-2 · Cited by 51 · see citing works
Improving cervical cancer screening in Mexico: results from the Morelos HPV Study
Flóres, Y. N., Bishai, D. M., Lazcano-Ponce, E. C., Shah, K. V., Lorincz, A. T., Hernández, M., Salmerón, J., Ferris, D. G., Hernández, P., Sherman, M. E., et al. (2003) · Salud Pública de México · doi:10.1590/s0036-36342003000900013 · Cited by 49 · see citing works
Abuelo, C., Levinson, K. L., Salmerón, J., Sologuren, C. V., Fernandez, M. J. V., & Belinson, J. L. (2013) · Journal of Community Health · doi:10.1007/s10900-013-9786-6 · Cited by 48 · see citing works
(CINCO), F. T. C. T. I. N. C. O., Winer, R. L., Gonzales, A. A., Noonan, C., Cherne, S., & Buchwald, D. (2016) · Journal of Community Health · doi:10.1007/s10900-016-0189-3 · Cited by 48 · see citing works
Guan, Y., Castle, P. E., Wang, S., Li, B., Feng, C.-Y., Ci, P., Li, X., Gravitt, P. E., & Qiao, Y. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050477 · Cited by 45 · see citing works
van de Wijgert, J. H. H. M., Altini, L., Jones, H. E., de Kock, A., Young, T., Williamson, A., Hoosen, A. A., & Coetzee, N. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204671.62529.1f · Cited by 44 · see citing works
Cadman, L., Ashdown-Barr, L., Waller, J., et al. (2014) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2013-100705 · Cited by 44 · see citing works
Vanderpool, R. C., Jones, M. G., Stradtman, L. R., et al. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.10.008 · Cited by 43 · see citing works
Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening
Dareng, E., Jedy-Agba, E. E., Bamisaye, P., Modibbo, F. I., Oyeneyin, L. O., Adewole, A., Olaniyan, O., Dakum, P., Pharoah, P. D. P., & Adebamowo, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141679 · Cited by 43 · see citing works
Comparison of non-invasive sampling methods for detection of HPV in rural African women
Lack, N. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.010413 · Cited by 42 · see citing works
Burton-Jeangros, C., Fargnoli, V., & Petignat, P. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s90772 · Cited by 42 · see citing works
Hanley, S. J. B., Fujita, H., Yokoyama, S., Kunisawa, S., Tamakoshi, A., Dong, P., Kobayashi, N., Watari, H., 工藤, 正., & Sakuragi, N. (2016) · Journal of Medical Screening · doi:10.1177/0969141315625702 · Cited by 39 · see citing works
The Peru Cervical Cancer Prevention Study (PERCAPS): The technology to make screening accessible
Levinson, K. L., Abuelo, C., Salmerón, J., Chyung, E., Zou, J., Belinson, S., Wang, G., Santos, C., Vallejos, C. S., & Belinson, J. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.026 · Cited by 38 · see citing works
Katz, M. L., Zimmermann, B. J., Moore, D., et al. (2016) · Women & Health · doi:10.1080/03630242.2016.1243608 · Cited by 38 · see citing works
Feasibility of Community-Based careHPV for Cervical Cancer Prevention in Rural Thailand
Trope, L. A., Chumworathayi, B., & Blumenthal, P. D. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31826b7b70 · Cited by 37 · see citing works
Harper, D. M., Raymond, M., Noll, W. W., et al. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200211000-00003 · Cited by 37 · see citing works
Acceptability of Self-Sampling HPV Testing Among Thai Women for Cervical Cancer Screening
Oranratanaphan, S., Termrungruanglert, W., & Khemapech, N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7437 · Cited by 37 · see citing works
Maza, M., Melendez, M., Masch, R., Alfaro, K., Chacon, A., Gonzalez, E., Soler, M., Conzuelo-Rodriguez, G., Gage, J. C., Alonzo, T. A., et al. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.06.017 · Cited by 37 · see citing works
Quincy, B. L., Turbow, D. J., & Dabinett, L. N. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.625456 · Cited by 36 · see citing works
Wong, E. L., Chan, P. K. S., Chor, J. S. Y., Cheung, A. W.-L., Huang, F., & Wong, S. Y. S. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000241 · Cited by 36 · see citing works
Wong, J. P., Vahabi, M., Miholjcic, J., Tan, V., Owino, M., Li, A. T. W., & Poon, M. K.-L. (2018) · Current Oncology · doi:10.3747/co.25.3855 · Cited by 35 · see citing works
Acceptability of cervical and anal HPV self-sampling in a sample of Hispanic women in Puerto Rico.
Ortiz, A. P., Alejandro, N., Pérez, C. M., et al. (2012) · PubMed · Cited by 34 · see citing works
HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile
Léniz, J., Barriga, M. I., Marcela Lagos, L., Ibáñez, C., Püschel, K., & Catterina Ferreccio, R. (2013) · Salud Pública de México · doi:10.1590/s0036-36342013000200007 · Cited by 30 · see citing works
Rodrigues, L. L. S., Morgado, M. G., Sahasrabuddhe, V. V., De Paula, V. S., Oliveira, N. S., Chavez-Juan, E., Da Silva, D. M., Kast, W. M., Nicol, A. F., & Pilotto, J. H. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.08.004 · Cited by 29 · see citing works
Lindell, M., Sanner, K., Wikström, I., & Wilander, E. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03147.x · Cited by 28 · see citing works
Jones, H. E., Wiegerinck, M. A. H. M., Nieboer, T. E., et al. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181812cf0 · Cited by 28 · see citing works
Peñaranda, E., Molokwu, J., Hernandez, I. C., et al. (2014) · Southern Medical Journal · doi:10.14423/smj.0000000000000132 · Cited by 27 · see citing works
Kilfoyle, K. A., Marais, A. C. D., Ngo, M. A., Romocki, L. S., Richman, A. R., Barclay, L. B., Brewer, N. T., Rahangdale, L., & Smith, J. S. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000430 · Cited by 27 · see citing works
Podolak, I., Kisia, C., Omosa-Manyonyi, G. S., & Cosby, J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2160-0 · Cited by 25 · see citing works
Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Taepisitpong, C., Krongthong, W., & Saeloo, S. (2018) · Journal of Community Health · doi:10.1007/s10900-017-0460-2 · Cited by 24 · see citing works
Mahomed, K., Evans, D., Sauls, C., Richter, K., Smith, J., & Firnhaber, C. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.17.189.3454 · Cited by 23 · see citing works
Mbatha, J. N., Galappaththi-Arachchige, H. N., Mtshali, A., Taylor, M., Ndhlovu, P. D., Kjetland, E. F., Baay, M. F. D., & Mkhize-Kwitshana, Z. L. (2017) · BMC Research Notes · doi:10.1186/s13104-017-3045-3 · Cited by 23 · see citing works
Sy, A. U., Hernandez, B. Y., Tareg, A., Reichhardt, M., & Buenconsejo-Lum, L. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.07.008 · Cited by 21 · see citing works
Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries?
(2020) · AMA Journal of Ethics · doi:10.1001/amajethics.2020.116 · Cited by 20 · see citing works
Wong, E. L. Y., Cheung, A. W. L., Huang, F., & Chor, J. S. Y. (2018) · Cancer Nursing · doi:10.1097/ncc.0000000000000462 · Cited by 19 · see citing works
Castell, S., Krause, G., Schmitt, M., Pawlita, M., Deleré, Y., Obi, N., Flesch‐Janys, D., Kemmling, Y., & Kaufmann, A. M. (2014) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2054-9 · Cited by 18 · see citing works
Aiko, K., Motoki, Y., Saito, O. M., Asano, R., Maruyama, Y., Asai‐Sato, M., Yamanaka, T., Hirahara, F., & Miyagi, E. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13258 · Cited by 18 · see citing works
Chen, S., Hsieh, P.-C., Chou, C.-H., & Tzeng, Y. (2014) · BMC Women s Health · doi:10.1186/preaccept-4942375021314755 · Cited by 17 · see citing works
Esber, A. L., McRee, A., Turner, A. N., Phuka, J. C., & Norris, A. H. (2016) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2015-101305 · Cited by 17 · see citing works
Morán, F., Cárcamo, C., Valderrama, M., et al. (2017) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2017.342.2453 · Cited by 14 · see citing works
Andersson, S., Belkić, K., Mints, M., & Östensson, E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199038 · Cited by 14 · see citing works
Molokwu, J., Peñaranda, E., Dwivedi, A. K., Mallawaarachchi, I. V., & Shokar, N. K. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000424 · Cited by 14 · see citing works
Yoshida, T., Nishijima, Y., Hando, K., et al. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.3029 · Cited by 13 · see citing works
Acceptability of self-sampling in Portuguese women: the good, the bad or the ugly?
Silva, J., Cerqueira, F., & Medeiros, R. (2017) · Sexual Health · doi:10.1071/sh16077 · Cited by 8 · see citing works
Decision-making about cervical cancer screening methods by homeless women.
Pieters, H. C., & Wiley, D. J. (2013) · PubMed · Cited by 2 · see citing works
Dareng, E., Jedy-Agba, E. E., Bamisaye, P., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000479597.35968.38 · Cited by 1 · see citing works
Chen, S.-L., Hsieh, P.-C., Chou, C.-H., et al. (2014) · BMC Women's Health · doi:10.1186/s12905-014-0139-0
Flagged first, then by citations
Research works printed but not linked: 1
- Giorgi Rossi, 2013, Hpv self-sampling, Int J Gynecol Cancer, 23, 43
Cited by
Sorted by citations
Worldwide use of HPV self-sampling for cervical cancer screening
Serrano, B., Ibáñez, R., Robles, C., Peremiquel‐Trillas, P., de Sanjosé, S., & Bruni, L. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106900 · Cited by 298 · see citing works
SKCV: Stratified K-fold cross-validation on ML classifiers for predicting cervical cancer
Prusty, S., Patnaik, S., & Dash, S. K. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.972421 · Cited by 250 · see citing works
“A DoS detection system based on a machine learning method for DAR-ML (Dynamic Secure Aware Routing by Machine Learning) would aid in the resolution of healthcare data (Nishimura et al., 2021).”
MethodCosta, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02094-w · Cited by 139 · see citing works
“The offer at a healthcare service, also seems to be a promising strategy to improve screening participation rates since similarly to the community mobilisation & outreach scenario, it benefits from the face-to-face invitation, also giving women the chance to clarify any doubts that might exist with regards to the inst…”
BackgroundHuman Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?
Milano, G., Guarducci, G., Nante, N., et al. (2023) · Vaccines · doi:10.3390/vaccines11061060 · Cited by 76 · see citing works
Zhao, S., Huang, L., Basu, P. S., Domingo, E. J., Supakarapongkul, W., Ling, W. Y., Ocviyanti, D., Rezhake, R., Qiao, Y., Tay, E. H., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.036 · Cited by 75 · see citing works
Jain, M., Yadav, D., Jarouliya, U., Chavda, V. K., Yadav, A. K., Chaurasia, B. K., & Song, M. (2023) · Pathogens · doi:10.3390/pathogens12121380 · Cited by 68 · see citing works
“Comprehensive surveillance programs at national or subnational levels targeting these three pillars (screening, vaccination, and treatment) are a framework in the WHO Global Strategy to reduce cervical cancer for public health concerns [157].”
BackgroundGennaro, G. D., Licata, F., Trovato, A., & Bianco, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1003461 · Cited by 69 · see citing works
Wang, W., Kothari, S., Skufca, J., et al. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2129615 · Cited by 59 · see citing works
HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
Włoszek, E., Krupa, K., Skrok, E., Budzik, M. P., Deptała, A., & Badowska-Kozakiewicz, A. M. (2025) · Current Oncology · doi:10.3390/curroncol32030122 · Cited by 59 · see citing works
“Even so, some women prefer clinician-collected samples because they are concerned about their ability to collect a reliable sample on their own [101].”
Hakim, R. U., Amin, T., & Islam, S. M. B. U. (2025) · Cancer Control · doi:10.1177/10732748251336415 · Cited by 38 · see citing works
“The immature cervix, especially the transformation zone where columnar epithelial cells are exposed during adolescence, is more susceptible to HPV. 46 Furthermore, improved compliance with contraceptives has not occurred and as such younger women are likely to lapse on contraceptives, thus…”
Castle, P. E. (2024) · Viruses · doi:10.3390/v16091357 · Cited by 38 · see citing works
“However, one of the primary barriers to the acceptance of self-collection is a lack of self-efficacy (i.e., women are concerned as to whether they can complete it “as well as the clinicians”), and women cite this as a reason that they might prefer provider-collected cervical specimens [130–132].”
BackgroundPrevalence and Genotype Distribution of Human Papillomavirus Infection among 12 076 Iranian Women
Bitarafan, F., Hekmat, M. R., Khodaeian, M., Razmara, E., Ashrafganjoei, T., Gilani, M. M., Mohit, M., Aminimoghaddam, S., Cheraghi, F., Khalesi, R., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.071 · Cited by 33 · see citing works
Detection of endometrial cancer using tampon-based collection and methylated DNA markers
Bakkum-Gamez, J. N., Sherman, M. E., Slettedahl, S. W., Mahoney, D. W., Lemens, M. A., Laughlin-Tommaso, S. K., Hopkins, M. R., VanOosten, A. L., Shridhar, V., Staub, J. K., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.04.014 · Cited by 30 · see citing works
Sy, F., Greuel, M., Winkler, V. F., Bussmann, H., Bärnighausen, T., & Deckert, A. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.06.012 · Cited by 30 · see citing works
Aimagambetova, G. N., Atageldiyeva, K. K., Marat, А., et al. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102590 · Cited by 29 · see citing works
“…studies assessing the acceptability of HPV self-sampling devices and strongly support “ inclusion of self-sampling for HPV testing ” as an additional approach for cervical cancer screening programs where HPV DNA testing is used (Verdoodt et al., 2015; Morgan et al., 2019; Nishimura et al., 2021).”
BackgroundInfluentialKotal, H., Kalyani, T., Sangili, A., et al. (2024) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/ad281b · Cited by 26 · see citing works
Symmons, S. M., Waller, J., & McBride, E. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101529 · Cited by 25 · see citing works
“HPV self-sampling has been introduced recently in some countries targeted at women who have not attended routine screening and has been found to be acceptable to women regardless of demographic characteristics (Nishimura et al., 2021).”
BackgroundMethodLe, D., Ciceron, A. C., Jeon, M. J., Gonzalez, L. I., Jordan, J. A., Bordón, J., & Long, B. J. (2022) · Current Oncology · doi:10.3390/curroncol29020047 · Cited by 26 · see citing works
Sormani, J., Kenfack, B., Wisniak, A., Datchoua, A. M., Makajio, S. L., Schmidt, N. C., Vassilakos, P., & Petignat, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010054 · Cited by 23 · see citing works
“This approach reduces the discomfort and pain that can be associated with pelvic examination, is considered less invasive, allows women more autonomy and privacy, and might facilitate screening participation [8,13,14].”
BackgroundDick, S., Heideman, D. A. M., Berkhof, J. H., Steenbergen, R. D. M., & Bleeker, M. C. G. (2024) · Tumour Virus Research · doi:10.1016/j.tvr.2024.200308 · Cited by 24 · see citing works
Bogale, A. L., Teklehaymanot, T., Haidar, J., Kassie, G. M., Medhin, G., Yizengaw, A., & Yilma, A. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01944-2 · Cited by 22 · see citing works
“Studies indicated that HPV self-sampling was the potential to increase the coverage of cervical cancer screening [40] and highly accepted cervical cancer screening method for end users [41, 42], that complements recent screening program by increasing population coverage [33].”
BackgroundDrysdale, H., Marlow, L. A. V., Lim, A. W., & Waller, J. (2024) · Health Expectations · doi:10.1111/hex.14118 · Cited by 21 · see citing works
“Clear step ‐ by ‐ step instructions and the opportunity to ask healthcare professionals questions, can help reassure women that they are collecting a sample correctly [13].”
BackgroundBorek, A., Roleston, C., Lazzarino, R., Cooray, M., Hayward, G., Roberts, N. W., Blandford, E., Fowler, T., & Tonkin-Crine, S. K. (2025) · BMC Public Health · doi:10.1186/s12889-025-21773-w · Cited by 18 · see citing works
Veerus, P., Hallik, R., Jänes, J., Jõers, K., Paapsi, K., Laidra, K., & Innos, K. (2021) · Journal of Medical Screening · doi:10.1177/09691413211052499 · Cited by 19 · see citing works
Arrivillaga, M., Bermúdez, P. C., García-Cifuentes, J. P., Rodríguez‐López, M., Neira, D., & Cardona, H. D. V. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14289 · Cited by 24 · see citing works
Ibáñez, R., Roura, E., Acera, A., Andújar, M., Pavón, M. Á., Bruni, L., & de Sanjosé, S. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107571 · Cited by 19 · see citing works
de la Cruz, S. P., & Cebrino, J. (2022) · Cancers · doi:10.3390/cancers14102481 · Cited by 17 · see citing works
“Here, there is evidence that HPV self-sampling has the potential to increase access to and adoption of screening globally [36], and in fact, self-sampling is now being tested in Spain [37].”
BackgroundGrulich, A. E., Mercer, C. H., Sturrock, B. R., Baral, S., Turpin, N., Phanuphak, N., Rowley, J. T., Wi, T., Gemzell‐Danielsson, K., Garcia‐Moreno, C., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01188-2 · Cited by 18 · see citing works
Tatar, O., Haward, B., Zhu, P., Griffin-Mathieu, G., Perez, S., McBride, E., Lofters, A., Smith, L., Mayrand, M., Daley, E. M., et al. (2023) · Current Oncology · doi:10.3390/curroncol30010093 · Cited by 16 · see citing works
“The Concerns factor included an item pertaining to confidence in using a self-sampling kit and the potential for harm with self-sampling, which were both commonly reported components of self-sampling acceptability identified in systematic reviews [19,20].”
BackgroundHuang, Q., & Tan, L.-Y. (2024) · Cancers · doi:10.3390/cancers16203475 · Cited by 16 · see citing works
“Such initiatives could also potentially facilitate early detection, enhance treatment outcomes, and ultimately reduce the overall cervical cancer burden within the population.”
BackgroundZigras, T., Mayrand, M., Bouchard, C., Salvador, S., Eiriksson, L. R., Almadin, C., Kean, S., Dean, E. A., Malhotra, U., Todd, N. J., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060425 · Cited by 15 · see citing works
“Regardless, the authors reported that high levels of acceptability were consistent among vulnerable and under-screened populations in the review [39].”
BackgroundChakravarti, P., Maheshwari, A., Tahlan, S., Kadam, P. R., Bagal, S. S., Gore, S., Panse, N. S., Deodhar, K., Chaturvedi, P., Dikshit, R. P., et al. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1427 · Cited by 14 · see citing works
Du, H., Dai, W., Zhou, Q., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1290112 · Cited by 14 · see citing works
Redefining precision cancer prevention to promote health equity
Butler, E. N., Umar, A., Heckman‐Stoddard, B. M., et al. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.01.009 · Cited by 14 · see citing works
Ploysawang, P., Pitakkarnkul, S., Kolaka, W., Ratanasrithong, P., Khomphaiboonkij, U., Tipmed, C., Seeda, K., Pangmuang, P., & Sangrajrang, S. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.2.607 · Cited by 13 · see citing works
“Several studies showed that women preferred clinician sampling over self-sampling because of a lack of confidence in performing the test (Williams et al., 2017; Nishimura et al., 2021).”
BackgroundMolecular triaging options for women testing HPV positive with self-collected samples
Taghavi, K., Zhao, F., Downham, L., Baena, A., & Basu, P. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1243888 · Cited by 14 · see citing works
“8) (8) and samples for self-collected hrHPV testing is well accepted by women in a range of different contexts (3, 8, 29), it is logical to offer this option in screening regimes.”
BackgroundDartibale, C. B., Prado, G. D. C., Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., Morelli, F., Souza, R. P., Group PREVENT YOURSELF, da Silva, V. R. S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.948471 · Cited by 14 · see citing works
Adegboyega, A., Desmennu, A. T., & Dignan, M. (2021) · Ethnicity and Health · doi:10.1080/13557858.2021.1980771 · Cited by 12 · see citing works
“…have been identified among women globally, including the ability to perform the self-sampling correctly, fear of self-harm, lack of confidence in test accuracy, and concerns about self-sampling replacing gynecological visits (Howard et al. 2009; Berner et al. 2013; Nishimura et al. 2021).”
BackgroundChao, C., Chubak, J., Beaber, E. F., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5226 · Cited by 11 · see citing works
Otieno, J. A., Were, L. M., Nyanchoka, M., Olwanda, E. E., Mulaku, M., Sem, X., Kohli, M., Markby, J. L., Muriuki, A., & Ochodo, E. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439164 · Cited by 15 · see citing works
Higashi, R. T., Tiro, J. A., Winer, R. L., et al. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102169 · Cited by 11 · see citing works
Xiong, S., Ghebre, R. G., Kulasingam, S., Mason, S. M., Pratt, R. J., & Lazovich, D. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102243 · Cited by 12 · see citing works
Haward, B., Tatar, O., Zhu, P., Griffin-Mathieu, G., McBride, E., Waller, J., Brotherton, J. M. L., Lofters, A., Mayrand, M., Perez, S., et al. (2023) · Current Oncology · doi:10.3390/curroncol30070512 · Cited by 10 · see citing works
“This is consistent with extant findings that suggest fears about sample reliability and the collection procedure are the primary concerns of individuals using self-sampling [10,48,52].”
BackgroundResultBasagoitia, A., Burrowes, S., Solís-Soto, M. T., et al. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02500-2 · Cited by 9 · see citing works
Hui, L., Liu, Y., Yin, S., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1481626 · Cited by 9 · see citing works
“%) poses challenges in detecting high-grade lesions and contributes to potential underdiagnosis issues (32, 33).”
Bonniec, A. L., Sauvaget, C., Lucas, E., Nassiri, A., & Selmouni, F. (2025) · JMIR Cancer · doi:10.2196/70251 · Cited by 9 · see citing works
“Our results are in accordance with international evidence, showing that HPVss is generally acceptable to women, but a lack of self-confidence with collecting a reliable sample can be a barrier to choosing this option [7].”
Griffin-Mathieu, G., Haward, B., Tatar, O., Zhu, P., Perez, S., Shapiro, G. K., McBride, E., Thompson, E. L., Smith, L., Lofters, A., et al. (2022) · JMIR Research Protocols · doi:10.2196/38917 · Cited by 10 · see citing works
Song, J., Ni, Y.-H., Fang, J., et al. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03186-w · Cited by 8 · see citing works
“A global systematic evaluation reported a range of self-sampling choices from 50–93% [8].”
BackgroundResultMiazga, W., Tatara, T., Wnuk, K., et al. (2024) · Cancers · doi:10.3390/cancers16122244 · Cited by 8 · see citing works
“However, the second study did not directly compare the preference regarding the collection of urine samples with the preference regarding the self-sampling of vaginal swabs [11].”
BackgroundA New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling
Lichtenfels, M., Lorenzi, N. P. C., Tacla, M., Yokochi, K., Frustockl, F. C., Silva, C. A., da Silva, A. L., Termini, L., & de Farias, C. B. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1770134 · Cited by 10 · see citing works
“The studies evaluating other cervical collectors used HC2 assay to detect HPV-DNA (16,18,31,33,35,39,45,51,52,56,68,69 and 68) and swab, spatula/Cytobrush, cervix broom brush, and Digene sampler for cervicovaginal sampling.”
BackgroundInfluentialNarvaez, L., Viviano, M., Dickson, C., & Jeannot, É. (2023) · Public Health in Practice · doi:10.1016/j.puhip.2023.100417 · Cited by 10 · see citing works
Nitkowski, J., Giuliano, A. R., Ridolfi, T., et al. (2023) · LGBT Health · doi:10.1089/lgbt.2023.0012 · Cited by 8 · see citing works
“Similar to cervicovaginal HPV self-sampling for cervical cancer screening, 6–9 anal HPV self-sampling is emerging as a potential method to screen for anal cancer.”
Dau, H., Nankya, E., Naguti, P., Basemera, M., Payne, B. A., Vidler, M., Singer, J., McNair, A., AboMoslim, M., Smith, L., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002554 · Cited by 8 · see citing works
“One of the most demonstrated practical, efficient, and effective ways to achieve this is through a human papillomavirus (HPV)-based self-sampling program [39].”
BackgroundDuan, R., Yang, H., Zhai, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09292-5 · Cited by 7 · see citing works
“This acceptance rate was lower than those observed in more developed areas of China 16 and in some high-income countries 17 .”
Tang, J. H., Lee, F., Chagomerana, M., et al. (2023) · Cancers · doi:10.3390/cancers15102797 · Cited by 7 · see citing works
“HPV self-collection is highly acceptable among women, regardless of age, income, or country of residence [10], and is similarly accurate as provider-collected samples when highly sensitive hrHPV assays are used [11].”
MethodGoff, J. L., Duc-Banaszuk, A.-S. L., Lefeuvre, C., Pivert, A., Ducancelle, A., Pauw, H. D., Arbyn, M., Vinay, A., & Rexand-Galais, F. (2023) · Cancers · doi:10.3390/cancers15215163 · Cited by 8 · see citing works
“Women appear to appreciate and better accept self-sampling [4], preferring it over clinician-sampling [5].”
BackgroundCora‐Cruz, M. S., Martínez, O., Perez, S., & Fang, C. Y. (2024) · Cancer Medicine · doi:10.1002/cam4.70098 · Cited by 8 · see citing works
“45 In the present review, we did not observe any distinct patterns in preference for self-sampling by setting (clinic vs. home); however, the location of self-collection was not always specified or it was variable even within a particular study (e.g., self-sampling could be performed at the…”
BackgroundNjoku, R. C., Martinelli, M., Giubbi, C., Marco, S. D., Torsello, B., d’Avenia, M., Sironi, M., Bianchi, C., & Cocuzza, C. E. (2024) · Diagnostics · doi:10.3390/diagnostics14192194 · Cited by 7 · see citing works
“Self-collected sampling has been widely accepted as a method of cervical screening, especially in low-income and middle-income countries [6–10].”
MethodRajkhowa, P., Mathew, M., Fadra, R., Saha, S., Rakshitha, K., Narayanan, P., & Brand, H. (2024) · Cancer Causes & Control · doi:10.1007/s10552-024-01923-y · Cited by 7 · see citing works
Boitano, T. K. L., Powell, M. A., Leath, C. A., Straughn, J. M., & Scarinci, I. C. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.100950 · Cited by 7 · see citing works
Ruel-Laliberté, J., Jacob‐Wagner, M., Bestman‐Smith, J., et al. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.02.012 · Cited by 7 · see citing works
Mackay, O., Lifford, K., Kalra, A., & Williams, D. (2024) · Journal of Medical Screening · doi:10.1177/09691413241274312 · Cited by 6 · see citing works
“A previous review found the home to be a highly acceptable setting for HPVSS, but women were found to prefer clinic-based sampling if sampling in the home meant they would not have access to an HCP. 26 Using CHWs combines the ben-e fi ts of home-based self-sampling with the support and reassur-ance offered by a trusted…”
InfluentialQuality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing
d’Avenia, M., Dell’Anno, F., Martinelli, M., Santomauro, L., Njoku, R. C., Mühr, L. S. A., Iacobellis, M., & Cocuzza, C. E. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70482 · Cited by 6 · see citing works
“Self ‐ sampling studies have shown that some women prefer clinician ‐ collected samples due to concerns about their ability to perform self ‐ collection correctly [41], highlighting the need for confidence ‐ building measures and quality assurance strategies.”
Lobin, C., Orang’o, O., Were, E. O., Muthoka, K., Singh, K., Allegri, M. D., Obermann, K., Doeberitz, M. V. K., & Bussmann, H. (2024) · International Journal of Cancer · doi:10.1002/ijc.35036 · Cited by 8 · see citing works
Perkins, R. B., & Mitchell, E. (2023) · Journal of the National Medical Association · doi:10.1016/j.jnma.2023.02.006 · Cited by 6 · see citing works
Nair, V., Dau, H., Vidler, M., AboMoslim, M., Mutamba, B., Scott, M., Nesbitt, Z., Deodatha, J., Byiringiro, S. D., Niyotwiringiye, C., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002135 · Cited by 6 · see citing works
Dzobo, M., Dzinamarira, T., Strauss, M., & Mashamba-Thompson, T. P. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100414 · Cited by 6 · see citing works
Ibáñez, R., Roura, E., Morey, F., Andújar, M., Pavón, M. Á., Acera, A., Bruni, L., & de Sanjosé, S. (2024) · Cancers · doi:10.3390/cancers17010063 · Cited by 5 · see citing works
“SS can be used to improve screening coverage [18] particularly for the underscreened women in whom the majority of cervical cancers are diagnosed [9,19].”
Asensio-Puig, L., de Andrés-Pablo, Á., Khannous‐Lleiffe, O., Ibáñez, R., Acera, A., de Sanjosé, S., Gabaldón, T., Alemany, L., Bruni, L., & Pavón, M. Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115736 · Cited by 5 · see citing works
“In addition, the introduction of self-sampling collection for HPV testing has emerged as a safe, accessible approach, increasing participation among women who might otherwise avoid sample collection by clinicians, therefore enhancing access to the screening test [6–8].”
BackgroundParapob, N., Lekawanvijit, S., Tongsong, T., et al. (2024) · Obstetrics & Gynecology Science · doi:10.5468/ogs.24117 · Cited by 5 · see citing works
Direct-to-consumer testing – benefits for consumers, people with disease and public health
Hinzmann, R. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0007 · Cited by 5 · see citing works
Qu, S.-X., Ni, Y.-H., Qin, J., et al. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2204942 · Cited by 5 · see citing works
“They cared about whether they carried out self-sampling correctly and about the accuracy of the test result (Williams et al. 2017, Nishimura et al. 2021).”
BackgroundPreferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening
Liebermann, E., Fontenot, H. B., Lim, E., Matsunaga, M., Zimet, G. D., & Allen, J. D. (2023) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2023.05.114 · Cited by 6 · see citing works
Fontenot, H. B., Fuzzell, L. N., Brownstein, N. C., et al. (2024) · Women s Health Issues · doi:10.1016/j.whi.2024.05.005 · Cited by 5 · see citing works
Rose, S. B., McBain, L., Garrett, S. M., Bell, R. A. R., Innes, C., Whaiti, S. T., Tino, A. B., & Sykes, P. H. (2024) · Journal of Primary Health Care · doi:10.1071/hc24118 · Cited by 5 · see citing works
Hendrickx, J. O., Keer, S. V., Donders, G. G. G., Weyers, S., Doyen, J., Beyers, K., Rios-Cortes, A., Meers, N., Téblick, L., & Vankerckhoven, V. (2025) · Archives of Public Health · doi:10.1186/s13690-024-01490-3 · Cited by 5 · see citing works
“FVU offers advantages over other self-sampling meth-ods, such as lavage, brush, or tampon-based self-sampling, due to its non-invasive nature, ease of use, and the absence of penetrating procedures, which can enhance participant comfort and increase acceptance among diverse populations [23, 27–31].”
Sundqvist, A., Hellsten, C., Strander, B., Lindh, M., & Borgfeldt, C. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.15112 · Cited by 5 · see citing works
Cervical cancer elimination: what, how and WHO ?
Davies, J. C., Cao, J., Baker-Rand, H. L. A., Morrison, J., & Crosbie, E. J. (2025) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12984 · Cited by 4 · see citing works
Rakhat, A., Marat, А., Sakhipova, G., Sakko, Y., & Aimagambetova, G. N. (2026) · Sci · doi:10.3390/sci8010005 · Cited by 4 · see citing works
“…to screening, when the sample collection is performed by a clinician, usually faces many barriers, including a shortage of healthcare facilities, a lack of trained personnel, stigma, embarrassment, and cultural or logistical complications that prevent women from attending clinics [24,31,32,35–39].”
InfluentialHansen, B. T., Nygård, M., Castle, P. E., Burger, E. A., & Aasbø, G. (2024) · International Journal of Cancer · doi:10.1002/ijc.34989 · Cited by 4 · see citing works
“39 The sociodemographic profile of the present study population of long-term non-attending women differs from that of women in the general screening population.”
Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer
Zhu, Y., Hu, Y., Shi, J., et al. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231184995 · Cited by 4 · see citing works
“Recent HPV selfsampling techniques identified by convenient, comfortable and private, dramatically increase screening coverage.(30) In addition, new screening methods, such as DNA ploidy analysis, methylation detection and p16/Ki-67 double staining, also facilitate the identification of cervical precancer, which are c…”
MethodConstantinou, G., Ayers, S., Mitchell, E. J., et al. (2024) · Midwifery · doi:10.1016/j.midw.2024.104063 · Cited by 4 · see citing works
Danan, E. R., Amundson, E. C., Gowdy-Jaehnig, A., et al. (2024) · Women s Health Issues · doi:10.1016/j.whi.2024.05.003 · Cited by 4 · see citing works
Bénéteau, T., Groc, S., Murall, C. L., et al. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2024.2427223 · Cited by 4 · see citing works
Adegboyega, A., Wiggins, A. T., Williams, L. B., & Dignan, M. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01184-4 · Cited by 4 · see citing works
Chiereghin, A., Pizzi, L., Buriani, C., Sanna, T., Amico, A., Squillace, L., Molinari, E., Florean, M. S., Lanza, G., & Mezzetti, F. (2024) · Cancers · doi:10.3390/cancers16234071 · Cited by 3 · see citing works
“The literature reports that the self-sampling method can increase screening participation across countries with varying income levels, including low-, middle-and high-income nations [7,8].”
Gezels, E., Willems, S. J. T., Vanthomme, K., Keersse, L., & Roy, K. V. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251320178 · Cited by 3 · see citing works
“10,16,17 In several European countries SSKs are used in the population-based CCS program.”
Cyriac, J., Jenkins, G. D., Strelow, B., et al. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03741-z · Cited by 3 · see citing works
“Reassuringly, high acceptability of self-collection for CCS was reported in a systematic review of 72 studies including just over 52,000 women, with no significant differences by factors such as income or age [55].”
Zhou, X., Bao, R., Guan, X., Li, W., Yang, C., Zhu, R., Li, H., & Wang, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1586076 · Cited by 4 · see citing works
“Studies have shown that such mechanisms can signi fi cantly enhance adherence to health screening programs by creating a sense of responsibility and investment among participants (35).”
Peremiquel‐Trillas, P., Roura, E., Rangel, V., Morey, F., Font, R., Carvajal, M., Robles, C., Ibáñez, R., Pijuán, L., Tamarit, L., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1580665 · Cited by 4 · see citing works
Colling, A. M., Saunders, T., Creagh, N. S., et al. (2025) · Health Expectations · doi:10.1111/hex.70397 · Cited by 3 · see citing works
Rivero‐Mendoza, D., Gjoka, K., Singh, L., et al. (2025) · Health Promotion Practice · doi:10.1177/15248399251370668 · Cited by 3 · see citing works
“HPV self-collection is well recognized as a strategy that improves screening results because it addresses barriers to screening, such as lack of convenience and privacy (Mkuu et al., 2024; Nishimura et al., 2021).”
Qin, J., Martinez, G. M., Holt, H. K., et al. (2025) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006147 · Cited by 3 · see citing works
Todorova, I. L. G., Panayotova, Y., Kotzeva, T., et al. (2025) · Health Policy · doi:10.1016/j.healthpol.2025.105497 · Cited by 3 · see citing works
Service Accessibility as a Determinant of Cervical Cancer Screening in Gwanda District, Zimbabwe
Fennie, M., Timothy, L. L., & Yevonnie, C. (2023) · African Journal of Health Nursing and Midwifery · doi:10.52589/ajhnm-zfdwwlir · Cited by 3 · see citing works
Andrew-Bassey, U. I., Oke, D. O., Okunlola, M. A., & Morhason-Bello, I. O. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085408 · Cited by 3 · see citing works
Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the world
Akgör, U., Temiz, B. E., & Gultekin, M. (2024) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000998 · Cited by 4 · see citing works
Milanova, V., Gomes, M., Mihaylova, K., Twelves, J. L., Multmeier, J., McMahon, H., McCulloch, H., & Cuschieri, K. S. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01852-24 · Cited by 3 · see citing works
Hsiao, K., Lin, H.-L., Chen, H., et al. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101904 · Cited by 3 · see citing works
Olumodeji, A. M., Adefemi, A. K., Adedeji, M. O., et al. (2024) · African Health Sciences · doi:10.4314/ahs.v24i1.16 · Cited by 3 · see citing works
- Authors
- Nishimura, H., Yeh, P. T., Oguntade, H., Kennedy, C. E., & Narasimhan, M.
- Affiliations
- Johns Hopkins University (US)
- World Health Organization (CH)
- Corresponding author
- Nishimura, Holly
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2021-05
- Volume
- 6
- Issue
- 5
- Pages
- e003743
- ISSN
- 2059-7908 (ISSN-L)
- PMC
- PMC8137189
- OpenAlex
- W3163098986
- Semantic Scholar
- 230d785d63fd20da248338eef71b6ca8ac7b419f
- Cited by
- 222
- References
- 98
- Citations by year
- 2026: 53 · 2025: 57 · 2024: 46 · 2023: 39 · 2022: 17 · 2021: 10
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMJ Global Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- World Health Organization
- The Children's Investment Fund Foundation
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- HPV self-sampling, cervical cancer screening, HPV testing, end-user preferences, acceptability, cervical swabs, clinician-collected samples, home-based screening, women's health
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Uterine Cervical Neoplasms, Cross-Sectional Studies, Female, Humans, Middle Aged, Self Care, Papillomaviridae, Papillomavirus Infections, Alphapapillomavirus, Early Detection of Cancer, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review